Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer?
作者信息
Wu Ann Chen, McMahon Pamela, Lu Christine
机构信息
Precision Medicine Translational Research (PROMOTER) Center, Harvard Pilgrim Health Care, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA Pediatr. 2020 Sep 1;174(9):821-822. doi: 10.1001/jamapediatrics.2020.1522.
Abstract
摘要
相似文献
1
Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer?终结诊断之旅——全基因组测序是答案吗？
JAMA Pediatr. 2020 Sep 1;174(9):821-822. doi: 10.1001/jamapediatrics.2020.1522.
2
Ending a Diagnostic Odyssey: Family Education, Counseling, and Response to Eventual Diagnosis.结束诊断之旅：家庭教育、咨询与对最终诊断的应对
Pediatr Clin North Am. 2017 Feb;64(1):265-272. doi: 10.1016/j.pcl.2016.08.017.
3
Patient perspectives on whole-genome sequencing for undiagnosed diseases.患者对未确诊疾病全基因组测序的看法。
Per Med. 2017 Jan;14(1):17-25. doi: 10.2217/pme-2016-0050. Epub 2016 Nov 30.
4
Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases.全基因组测序作为罕见遗传病的一线诊断框架。
Exp Biol Med (Maywood). 2021 Dec;246(24):2610-2617. doi: 10.1177/15353702211040046. Epub 2021 Sep 15.
5
The diagnostic odyssey: our family's story.诊断之旅：我们家的故事。
Am J Hum Genet. 2021 Feb 4;108(2):217-218. doi: 10.1016/j.ajhg.2021.01.003.
6
A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.儿童罕见病的新方法：未确诊疾病网络。
J Pediatr. 2018 May;196:291-297.e2. doi: 10.1016/j.jpeds.2017.12.029. Epub 2018 Jan 11.
7
Attaining Diagnostic Excellence: How the Structure and Function of a Rare Disease Service Contribute to Ending the Diagnostic Odyssey.实现诊断卓越：罕见病服务的结构和功能如何有助于终结诊断之旅。
Med Clin North Am. 2024 Jan;108(1):1-14. doi: 10.1016/j.mcna.2023.06.013. Epub 2023 Jul 26.
8
The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic.医学基因组计划：将罕见病诊断的全基因组测序推向临床。
Genome Med. 2020 May 27;12(1):48. doi: 10.1186/s13073-020-00748-z.
9
Challenges and recommendations to increasing the use of exome sequencing and whole genome sequencing for diagnosing rare diseases in Brazil: an expert perspective.提高巴西罕见病诊断中使用外显子组测序和全基因组测序的挑战和建议：专家视角。
Int J Equity Health. 2023 Jan 13;22(1):11. doi: 10.1186/s12939-022-01809-y.
10
Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?迈向罕见病下一代测序基因检测的临床应用：我们在哪里？
Trends Genet. 2019 Nov;35(11):852-867. doi: 10.1016/j.tig.2019.08.006. Epub 2019 Oct 14.
引用本文的文献
1
Bridging psychiatry and rare genetic diseases: a scoping review of therapeutic strategies and diagnostic delay paired with healthcare economic burden analysis.连接精神病学与罕见遗传病：治疗策略及诊断延迟与医疗保健经济负担分析的范围综述
Orphanet J Rare Dis. 2025 Aug 1;20(1):393. doi: 10.1186/s13023-025-03941-8.
2
The role of genetic testing in small for gestational age infants.基因检测在小于胎龄儿中的作用。
J Perinatol. 2025 Jun 26. doi: 10.1038/s41372-025-02343-9.
3
Personal Health Record Software for Neuroendocrine Tumors: Patient-Centered Design Approach.神经内分泌肿瘤的个人健康记录软件：以患者为中心的设计方法。
JMIR Hum Factors. 2025 Jun 3;12:e68788. doi: 10.2196/68788.
4
The Financial Impact of Ehlers-Danlos Syndromes on Patients in the United States in 2022.2022年埃勒斯-丹洛斯综合征对美国患者的经济影响。
Mayo Clin Proc Innov Qual Outcomes. 2024 Dec 14;9(1):100586. doi: 10.1016/j.mayocpiqo.2024.11.003. eCollection 2025 Feb.
5
A Just Genomics Needs an ELSI of Translation.公正的基因组学需要转化的伦理、法律和社会影响研究。
Hastings Cent Rep. 2024 Dec;54 Suppl 2:S126-S135. doi: 10.1002/hast.4938.
6
Atypical Presentation of Congenital Insensitivity to Pain With Anhidrosis Leading to Diagnostic Odyssey.先天性无痛无汗症的非典型表现导致诊断探索。
Mol Genet Genomic Med. 2024 Oct;12(10):e70027. doi: 10.1002/mgg3.70027.
7
Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey.危重症婴儿的快速基因组测序：来自土耳其的一项开创性试点研究。
Front Pediatr. 2024 Jul 4;12:1412880. doi: 10.3389/fped.2024.1412880. eCollection 2024.
8
NeoGx: Machine-Recommended Rapid Genome Sequencing for Neonates.NeoGx：针对新生儿的机器推荐快速基因组测序
medRxiv. 2024 Jun 25:2024.06.24.24309403. doi: 10.1101/2024.06.24.24309403.
9
10
Clinically significant changes in genes and variants associated with epilepsy over time: implications for re-analysis.随着时间的推移，与癫痫相关的基因和变异的临床显著变化：重新分析的意义。
Sci Rep. 2024 Apr 2;14(1):7717. doi: 10.1038/s41598-024-57976-1.
本文引用的文献
1
A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants.一项在重症婴儿中比较单体和 trio、快速基因组和外显子组测序的分析和诊断性能的随机、对照试验。
Am J Hum Genet. 2019 Oct 3;105(4):719-733. doi: 10.1016/j.ajhg.2019.08.009. Epub 2019 Sep 26.
2
Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.外显子组和基因组测序结果披露相关的心理结果：七项临床测序探索性研究（CSER）联盟研究的荟萃分析。
Genet Med. 2019 Dec;21(12):2781-2790. doi: 10.1038/s41436-019-0565-3. Epub 2019 Jun 13.
3
Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.基因组和外显子组测序以及染色体微阵列在疑似遗传疾病儿童中的诊断及临床应用的荟萃分析。
NPJ Genom Med. 2018 Jul 9;3:16. doi: 10.1038/s41525-018-0053-8. eCollection 2018.
4
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.全外显子组和全基因组测序方法是否具有成本效益？文献系统评价。
Genet Med. 2018 Oct;20(10):1122-1130. doi: 10.1038/gim.2017.247. Epub 2018 Feb 15.
5
Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.全外显子测序对那些诊断之旅接近尾声的患者的效用：是时候解决护理中的差距了。
Clin Genet. 2016 Mar;89(3):275-84. doi: 10.1111/cge.12654. Epub 2015 Sep 22.
Zotero 插件